Theresa Heggie
Director · 2 filings · Latest: Jun 11, 2026
BIOCRYST PHARMACEUTICALS INC
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
BCRX | Theresa Heggie | Director | Mar 20, 2026 | Sale | $10.11 | 49,933 | $504.8K | 65,352 | |
BCRX | Theresa Heggie | Director | Mar 20, 2026 | Option Exercise | $6.30 | 49,933 | $314.6K | 115,285 | |
BCRX | HEGGIE THERESA | — | Mar 20, 2026 | Proposed Sale | $10.11 | 49,933 | $504.6K | — | |
BCRX | HEGGIE THERESA | — | Aug 13, 2025 | Proposed Sale | $8.51 | 70,000 | $595.9K | — |